Lexpos News

/Lexpos News/

April 2023 Category M prices announced

The Drug Tariff Category M pricelist for April 2023 has been published on the NHS Business Services Authority (NHSBSA) website. The April Category M prices reflect a moderate increase in reimbursement levels which is the net effect of 3 elements; A significant adjustment in Category M prices in recognition of the price rises that have [...]

The post April 2023 Category M prices announced appeared first on PSNC Website.

By |March 24th, 2023|Lexpos News|Comments Off on April 2023 Category M prices announced

HRT PPC: Guidance and FAQs now available

Ahead of the Government’s introduction of the new Prescription Prepayment Certificate (PPC) for hormone replacement therapy (HRT) products on 1 April, PSNC has published guidance and FAQs to help pharmacy teams to implement this new policy. Background and Latest Position From 1 April 2023, patients who are not already exempt from NHS prescription charges will be [...]

The post HRT PPC: Guidance and FAQs now available appeared first on PSNC Website.

By |March 24th, 2023|Lexpos News|Comments Off on HRT PPC: Guidance and FAQs now available

Save Our Pharmacies posters on the way

As part of the joint #SaveOurPharmacies campaign, the national pharmacy bodies have arranged for an A2 window poster to be sent to community pharmacies. The striking window posters are being distributed to all community pharmacies in England in the latest editions of Pharmacy Magazine and P3pharmacy. Pharmacy Magazine’s March edition will hit pharmacy doormats early [...]

The post Save Our Pharmacies posters on the way appeared first on PSNC Website.

By |March 24th, 2023|Lexpos News|Comments Off on Save Our Pharmacies posters on the way

Brand name prescribing status for Tacrolimus products updated on dm+d

Following representation from PSNC, the NHS Business Services Authority (NHSBSA) has added the ‘Caution – AMP level prescribing advised’ marker to oral Tacrolimus products on the Dictionary of medicines and devices (dm+d). This is in line with the MHRA guidance that oral Tacrolimus products should be prescribed and dispensed by brand name only, to minimise [...]

The post Brand name prescribing status for Tacrolimus products updated on dm+d appeared first on PSNC Website.

By |March 23rd, 2023|Lexpos News|Comments Off on Brand name prescribing status for Tacrolimus products updated on dm+d

MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited)

Drug alert number: EL(23)A/12 Date issued: 23 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) Batch number Expiry date Pack size First distributed T16656K Mar 2024 1 19 May 2022 U11271E Jun [...]

The post MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) appeared first on PSNC Website.

By |March 23rd, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited)